All
Andrology
Astronomy
Biochemistry
Bioinformatics
Biology
Biophysics
Biotechnology
Botany
Cardiology
Cell Biology
Chemistry
Dermatology
Ecology
Epidemiology
Evolutionary Biology
General
Genetics
Genomics
Geology
Geriatrics
Gynaecology
Immunology
Informatics
Mathematics
Medicine
Microbiology
Molecular Biology
Neurology
Nutrition
Oncology
Pathology
Pediatrics
Pharmacology
Philosophy
Physics
Physiology
Psychiatry
Psychology
Statistics
Surgery
Toxicology
Urology
Virology
Zoology
Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts
(British Journal of Cancer)
14 november 2018 05:00:11
Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts
(British Journal of Cancer)
Tweet
110 views
Category:
Oncology
Effect of home-based specialised palliative care and dyadic psychological intervention on caregiver anxiety and depression: a randomised controlled trial
(British Journal of Cancer)
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma
(British Journal of Cancer)
Please enable JavaScript to view the
comments powered by Disqus.
blog comments powered by
Disqus
MyJournals.org
The latest issues of all your favorite science journals on one page
Username:
Password:
Register
|
Retrieve
Search:
Google:
Copyright © 2008 - 2024
Indigonet Services B.V.
. Contact:
Tim Hulsen
. Read
here
our privacy notice.
Other websites of Indigonet Services B.V.:
Nieuws
Vacatures
News
Tweets
Nachrichten